VCVictor Chumpitaz-Cerrate

Victor Chumpitaz-Cerrate

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Victor Chumpitaz-Cerrate has a total of 105 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Assessment of Oral Mucosal Status in Populations Exposed to Different Concentrations of Arsenic in Drinking Water

    by Maria Esther Lobaton-Mego, Victor Manuel Chumpitaz-Cerrate, Alfredo Carlos Manuel Rendon-Alvarado

    Introduction: Arsenic (As) is a major public health concern due to its high toxicity and adverse effects on human health. The International Agency for Research on Cancer (IARC) has classified it as a human carcinogen, based on evidence linking its ingestion through drinking water to skin and lung cancer. The objective of this study was to assess oral mucosa status in populations exposed to different concentrations of As in a district of Lambayeque, Peru. Methods: an observational, descriptive, non-experimental, comparative study was conducted. The sample consisted of 164 patients. The Oral Assessment Guide was used as the evaluation instrument. Data were analyzed using inferential statistics (chi-square test). Results: no significant association was found between oral mucosa status and As concentration (p = 0.054). In the group exposed to high concentrations of As, 3.7 % showed alterations in oral cavity structures and 9.8 % presented severe alterations. Conclusion: although no statistically significant association was found, the results show a trend toward statistical significance (p = 0.054), suggesting that As exposure may negatively affect oral mucosa health in populations exposed to high concentrations.

  • Role of Corticosteroids as Adjunctive Therapy in Patients With Odontogenic Cervicofacial Infections: Systematic Review

    by Victor Chumpitaz‐Cerrate, Lesly Chávez‐Rimache, Patrick Guadalupe Aguilar, Claudia Gonzales Camacho, Maricé Pardavé‐Ponce, Angie Aponte‐Labán, Oskar Eduardo Prada Vidarte

    Objective: The main aim is to evaluate the efficacy and safety of corticosteroid administration as adjuvant therapy in patients with odontogenic cervicofacial infections. Methods: We searched five databases, grey literature and manually reviewed bibliographic references for observational studies. Outcomes included hospital length of stay, intensive care unit admission, reoperation and other postoperative complications. The risk of bias was assessed using the Newcastle‐Ottawa Scale. Meta‐analyses were not performed due to the heterogeneity of the results. Results: We included four observational studies. Dexamethasone use reduced the odds of reoperation (odds ratio (OR): 0.9; 95% CI: 0.8–0.98). Additionally, higher doses of dexamethasone were associated with a shorter hospital stay (β: −0.2; 95% CI: −0.3 to −0.07). However, another study reported a longer hospital stay among patients who received corticosteroids than those who did not; p < 0.001. Furthermore, corticosteroid use was associated with lower odds of intensive care unit admission (OR: 0.51; 95% CI: 0.09–2.72); p > 0.05. The only reported adverse event was prolonged hyperglycemia (0.8%). Conclusions: The adjuvant use of corticosteroids in managing patients with odontogenic cervicofacial infections has potential beneficial effects and appears safe. However, the evidence remains unclear, and further studies are needed to evaluate potential benefits and harms.

  • Therapeutic Equivalence of Multisource Drugs Assessed by In Vitro Dissolution Studies: Amoxicillin/Clavulanic Acid Tablets

    by Victor Chumpitaz-Cerrate, Luis Moreno-Exebio, Eliberto Ruiz-Ramirez, César Franco-Quino, María Flores-Rodríguez, Lesly Chávez-Rimache

  • Open Access

    Efecto del tratamiento con ácido zoledrónico e hidroxocobalamina sobre la microarquitectura ósea en ratones con periodontitis y osteoporosis inducida: Estudio preclínico

    by Marieta Petkova-Gueorguieva, César I. Franco-Quino, Victor M. Chumpitaz-Cerrate, Lesly K. Chavez-Rimache, Eliberto Ruiz-Ramirez, Vladimir E. Borda-Mendoza, Claudia A. Gonzales-Camacho, Angie S. Aponte-Laban

    Objective. Evaluate the effect of zoledronic acid and hydroxocobalamin treatment on alveolar bone microarchitecture in mice with induced periodontitis and osteoporosis. Methods. Experimental design in preclinical phase. Sixteen female mice were included in which osteoporosis was induced by total ovariectomy and periodontitis was also induced by inflammation by 5/0 black silk ligation of the maxillary second molar, all protocols were performed under general anesthesia. The mice were distributed into 4 groups: control, treatment with zoledronic acid, treatment with hydroxocobalamin and combined treatment. At 16 weeks, euthanasia was performed, dissection was performed for evaluation by microtomography; determining bone mineral density (BMD), bone volume (BV/TV), trabecular thickness (Tb.Th), number of trabeculae (Tb.N), trabecular separation (Tb.Sp); descriptive and bivariate analysis was performed using 1-way ANOVA with a 95% confidence level. Results. The group that received combined treatment of zoledronic acid and hydroxocobalamin presented higher bone mineral density (BMD), higher bone volume (BV/TV) and lower trabecular separation (Tb.Sp) compared to the control group (p<0.05). Conclusions. Combined treatment with zoledronic acid and hydroxocobalamin improves bone microarchitectural features in mice with induced osteoporosis and periodontitis.

  • Open Access

    Radical Surgical Approach to Chronic Suppurative Osteomyelitis: Case Report

    by Diana Carolina Vargas-Rojas, Arturo Rodriguez-Flores, David Moreno-Villalobos, Victor Chumpitaz-Cerrate, Lesly Chávez-Rimache

    Diabetes mellitus is a systemic condition potentially related to an increased risk of progression of various infections such as chronic osteomyelitis by accelerating the inflammatory process with bone tissue necrosis and suppuration. Therefore, if there is no proper management of these infections, they can be life-threatening as they spread to deeper spaces in the head and neck. We describe the case of a 52-year-old male patient with a history of diabetes mellitus and grade III osteoarthritis who was diagnosed with chronic suppurative osteomyelitis of the mandible. He underwent a multidisciplinary surgical intervention in which he underwent a hemimandibulectomy with immediate mandibular reconstruction. The present case highlights the importance of early and radical treatment of patients with chronic suppurative osteomyelitis of the mandible and systemic comorbidities. In addition, this case presents a review of diabetes mellitus and the risk of developing odontogenic infections and complications when invading deeper spaces in the head and neck. Therefore, in this population, careful planning is required for early surgical and pharmacological treatment.


  • Open Access

    Comparison of the anesthetic effect of alkalized lidocaine versus non-alkalized lidocaine administered at a slow rate in mandibular primary molars

    by Karen Torres-Rojas, Victor Chumpitaz-Cerrate, Lesly Chávez-Rimache, Daniella Núñez-Díaz, Vanessa Pérez-Jimenez

    Background. There are several invasive dental procedures that require local anesthetics. However, its infiltration is usually associated with anxiety and fear, increasing the perception of pain in pediatric patients. For this reason, it is important to evaluate different strategies for its application. We compared the anesthetic effect of the administration of 2% lidocaine with epinephrine 1:80000 non-alkalized at slow speed and alkalized at fast speed to block the inferior alveolar nerve in deciduous molars. Methods. A crossover clinical trial was carried out whose sample consisted of 38 patients between 6-10 years who required bilateral pulp treatment in their first mandibular primary molars. At the first appointment, they received 2% lidocaine with 1:80000 alkalinized epinephrine administered at a fast rate, and at the second appointment, 2% lidocaine with 1:80000 non-alkalized epinephrine administered at a low speed. We evaluated the onset of action, duration of the anesthetic effect, and intensity of pain during its infiltration. Results. We found that non-alkalized lidocaine at slow speed had a shorter onset time of action (57.21±22.21 seconds) and longer duration of effect (170.82±43.75 minutes) compared to administration of alkalinized lidocaine at fast speed (74.03±22.09 seconds, 148.24±36.24 minutes, respectively). There was no difference in the level of pain intensity. Conclusion. In this study, the slow administration of the non-alkalized local anesthetic showed a shorter onset time of action and a longer duration of the anesthetic effect in comparison with the alkalized local anesthetic administered at a rapid rate in the blockade of the inferior alveolar nerve in deciduous molars.


  • Open Access

    Fluorosis dental en adolescentes de Instituciones Educativas de Lima, Perú.

    by Victor Chumpitaz-Cerrate, Maricé Maribé Pardavé-Ponce, Lesly Chávez-Rimache, Carlos Erazo-Paredes, Vanessa Pérez-Jimenez

    Introducción: La fluorosis dental es una patología endémica causada por la ingestión excesiva de fluoruros que pueden producir una alteración durante el desarrollo del esmalte, y es considerado un importante problema de salud pública porque afecta la salud bucal y sistémica de la población. Objetivo: Este estudio tuvo como idea principal determinar la frecuencia y los niveles de fluorosis dental en escolares de 12 a 15 años pertenecientes a dos instituciones educativas de Lima - Perú. Método: Se realizó un estudio descriptivo de tipo transversal, la muestra estuvo conformada por 252 estudiantes, entre 12 y 15 años de dos centros educativos de Lima. El muestreo fue por selección sistemática de elementos muestrales. La fluorosis dental se evalúo mediante el Índice de Dean. Para determinar la frecuencia y los niveles de fluorosis dental, se realizó un examen clínico bucal y se desarrolló un cuestionario validado previamente. Resultados: La frecuencia de fluorosis dental fue de 44,8% (n=113) afectando más a los varones en un 27,39% (n=69) y a los adolescentes de 13 años (15,1%). En relación con los niveles de fluorosis, predominó el tipo “muy leve” (34,9%). También se encontró una asociación entre la presencia y el nivel de fluorosis con el número de aplicaciones de flúor (p<0,05). Además, se dijo que el índice comunitario de fluorosis de Dean fue de 0,43. Conclusiones: En la población escolar evaluada, la frecuencia de fluorosis fue de 44,8% y el nivel predominante de fluorosis fue muy leve. Además, el índice comunitario fue de 0,43, el cual mostró un nivel límite de importancia para la salud pública. Por lo que se puede considerar que el número de aplicaciones tópicas de flúor recibido por la población sin una planificación adecuada se podría convertir en un factor de riesgo para causar fluorosis dental.


  • Open Access

    Evaluation of Current Evidence on the Use of Oral Antiseptics Against SARS-CoV-2

    by Victor Chumpitaz-Cerrate, Lesly Chávez-Rimache, Eliberto Ruiz-Ramirez, César Franco-Quino, Carlos Erazo-Paredes

    Aims and Objectives: The detection of SARS-COV-2 in the oral cavity has generated endless claims about the efficacy of using oral mouthwashes to reduce viral load. This review aims to assess the current evidence on the use of oral antiseptics against SARS-CoV-2 and to assess the certainty of the evidence according to the GRADE system. The question this study focussed on was what is the efficacy of oral antiseptics against SARS-CoV-2? Materials and Methods: A bibliographic search was performed in Medline databases through PubMed, Science Direct, and Google Scholar (until February 2022), using search terms related to COVID-19 and oral antiseptics. Two independent researchers extracted the information from the articles included in an excel form. The identification and selection of the studies was carried out from August 2021 to February 2022. Results: It was found that oral antiseptics can have a potential beneficial effect on COVID-19, mainly in reducing viral load. However, these potential benefits are mainly based on in-vitro studies or clinical studies with various methodological limitations. At present, the certainty of the evidence is very low due to inconsistency (heterogeneity), moderate-to-high risk of bias, and imprecision of the results. Conclusion: The certainty of the current evidence on the efficacy of oral antiseptics against SARS-CoV-2 is very low, mainly due to the methodological limitations of the studies. Therefore, for evidence-based decision-making about this intervention, clinical studies with greater methodological rigor are required. Oral antiseptics could present potential benefits in patients with COVID-19 mainly by reducing viral load. However, a careful and conscious evaluation of the evidence is required for decision-making in clinical practice.


  • Need for randomized clinical Trials on the management of pain, inflammation and trismus in surgery of impacted third molars

    by Victor Chumpitaz-Cerrate, Lesly Chávez-Rimache, Eliberto Ruiz-Ramirez, Arturo Rodriguez-Flores

  • Therapeutic Equivalence Evaluated Through In Vitro Studies of Multi-Source Drugs: A Moxifloxacin Case Study in Lima, Peru

    by Victor Chumpitaz-Cerrate, Luis Moreno-Exebio, Eliberto Ruiz-Ramirez, César Franco-Quino, María Flores-Rodríguez, Lesly Chávez-Rimache